Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VM202 (Engensis) in painful diabetic peripheral neuropathy
NCT02427464Phase 3Completed
- Sponsor
- Helixmith
- Start
- Apr 2016
- Primary completion
- Apr 2019
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 1
01
Overview
A Phase 3 trial of Engensis in diabetic peripheral neuropathy (DPN), sponsored by Helixmith. Started Apr 2016; status: completed.
02
Drugs
Engensis
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02427464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427464.